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Programmed necrosis (or necroptosis) is a form of
cell death triggered by the activation of receptor
interacting protein kinase-3 (RIPK3). Several reports
have implicated mitochondria and mitochondrial
reactive oxygen species (ROS) generation as effec-
tors of RIPK3-dependent cell death. Here, we directly
test this idea by employing a method for the specific
removal of mitochondria via mitophagy. Mitochon-
dria-deficient cells were resistant to the mitochon-
drial pathway of apoptosis, but efficiently died via
tumor necrosis factor (TNF)-induced, RIPK3-depen-
dent programmed necrosis or as a result of direct
oligomerization of RIPK3. Although the ROS scav-
enger butylated hydroxyanisole (BHA) delayed TNF-
induced necroptosis, it had no effect on necroptosis
induced by RIPK3 oligomerization. Furthermore,
although TNF-induced ROS production was depen-
dent on mitochondria, the inhibition of TNF-induced
necroptosis by BHA was observed in mitochondria-
depleted cells. Our data indicate that mitochondrial
ROS production accompanies, but does not cause,
RIPK3-dependent necroptotic cell death.
INTRODUCTION
Apoptosis and programmed necrosis are two functionally linked
cell death pathways that can be triggered by ligation of members
of the ‘‘death receptor’’ (DR) family of cell surface receptors.
Apoptosis is orchestrated by activation of the caspase family878 Cell Reports 5, 878–885, November 27, 2013 ª2013 The Authorsof cysteine proteases, whereas programmed necrosis is initiated
by the receptor interacting protein kinase (RIPK) family members
RIPK1 andRIPK3. Signaling throughDRs such as tumor necrosis
factor receptor 1 (TNFR1) can lead either to apoptosis through
activation of Caspase-8 or to programmed necrosis via RIPK1-
RIPK3 signaling (He et al., 2009), and the latter is inhibited by
the action of a heterodimer of Caspase-8 and the Caspase-8-
like molecule c-FLIPL (Dillon et al., 2012; Oberst et al., 2011).
The signaling events that connect receptor ligation to RIPK3
activation have been extensively studied (Green et al., 2011). In
contrast, the mechanisms by which RIPK3 activity leads to cell
death are less clear, although several studies have implicated
mitochondria as downstream effectors of the process (Vanden
Berghe et al., 2010; Wang et al., 2012; Zhang et al., 2009).
Several reports have also indicated a requirement for ROS pro-
duction in the execution of RIPK3-dependent programmed
necrosis (Cho et al., 2009; Kim et al., 2007; Lin et al., 2004; Van-
den Berghe et al., 2010; Vanlangenakker et al., 2011; Zhang
et al., 2009). We sought to directly test the roles of mitochondria
andmitochondrial reactive oxygen species (ROS) in necroptosis.
RESULTS
Necroptosis Is Executed Independently ofMitochondrial
Permeability Transition
During apoptosis (Goldstein et al., 2000; Marzo et al., 1998) and
in some forms of necrosis (Baines et al., 2005), the mitochondrial
transmembrane potential (DJm) dissipates prior to loss of
plasma membrane integrity. We examined DJm during necrop-
tosis induced by treatment with TNF plus benzyloxycarbonyl-
Val-Ala-DL-Asp-fluoromethylketone (zVAD). We found that loss
of DJm did not occur until after the plasma membrane became
permeable (Figure 1A; Movie S1), suggesting that necroptosis
Figure 1. Necroptosis Is Executed Independently of Mitochondrial Permeability Transition
(A) SVEC cells were incubated with TMRE/Annexin V Alexa Fluor 488, treated with TNF+zVAD, and imaged by live-cell confocal microscopy. Images obtained
after initial treatment and at the point of cell lysis are shown. Arrow denotes the same cell at different time points.
(B) Expected and observed frequency of caspase-8/cyclophilin D status in offspring from crosses of cyclophilin D / caspase 8 +/ mice.
(C) Left: representative images of control or Parkin-expressing 3T3-SA cells treated ± CCCP for 48 hr and immunostained with Tom20 antibody. Right: quan-
titation of control or Parkin-expressing 3T3-SA or SVEC cells treated ± CCCP for 48 hr that lack mitochondrial Tom20 staining. A minimum of 100 cells were
counted per condition per experiment. Error bars represent the SD from the mean of three independent experiments.
(D) Control or Parkin-expressing 3T3-SA cells were treated with CCCP for 48 hr and protein expression was monitored by western blot. Actin was used as a
loading control.
(E) Parkin-expressing 3T3-SA cells were treatedwithCCCP for 48 hr and assayed formtDNA copy number per nuclear genome. Error bars represent the SD from the
meanof triplicatesamples.Dataare representativeof three independentexperiments.Thesamepoolofcellswasused for theEManalysisshown inFigures2Aand2B.
(F) Control or Parkin-expressing 3T3-SA cells were treated with CCCP for 48 hr; oxygen consumption was determined and is displayed relative to the untreated
control. Error bars represent the SD from the mean of triplicate samples. Data are representative of three independent experiments.
See also Figure S1 and Movie S1.
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Figure 2. TNF-Dependent Necroptosis Does Not Require Mitochondria
(A) Representative TEM images of control or CCCP-treated 3T3-SA Parkin-expressing cells; arrows denote mitochondria.
(B) Representative 3D-EM images of control or CCCP-treated 3T3-SA Parkin-expressing cells. Mitochondria are colored red and cytosol is colored
blue.
(C) 3D-EM quantification of mitochondrial mass of Parkin-expressing 3T3-SA cells treated with CCCP for 48 hr. Black squares represent the area mitochondria/
area cytosol ratio, expressed as percentage (% area mitochondria/area cytosol); white circles represent the percentage of the volume mitochondria/volume
cytosol ratio. For further information, see Experimental Procedures. *p < 0.0001, **p < 0.05.
(D) Control or Parkin-expressing 3T3-SA or SVEC cells were treatedwith CCCP for 48 hr and then treatedwith the indicated stimuli for 8 hr (TNF+zVAD, TNF+CHX)
or overnight with STS or ActD. Cell death was determined by PI positivity and flow cytometry.
(legend continued on next page)
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does not require the mitochondrial permeability transition (MPT),
which immediately dissipates DJm (Marzo et al., 1998). In sup-
port of this finding, and in contrast to RIPK3 deletion, loss of cy-
clophilin D (a key component of the MPT pore [Baines et al.,
2005]) failed to rescue embryonic lethality in Caspase-8 deficient
mice (Figure 1B). These and other data (Ch’en et al., 2011)
strongly suggest that if mitochondria act as important effectors
of necroptosis, they do not do so through the MPT.
To definitively determine the importance of mitochondria as
potential effectors in necroptosis, we sought to generate mito-
chondria-deficient cells. Previous studies have shown that Par-
kin induces the removal of mitochondria lacking DJm through
the process of mitophagy, and that extensive Parkin-mediated
mitophagy can fully deplete all mitochondria in a cell (Narendra
et al., 2008). We therefore generated SVEC or 3T3-SA cells sta-
bly expressing YFP-Parkin and treated them with the protono-
phore carbonylcyanide m-chlorophenylhydrazone (CCCP) for
2 days. Mitochondrial content was assessed by immunostaining
for the mitochondrial protein Tom20 (Figure 1C) or by western
blotting for the mitochondrial proteins Tom20 and cytochrome
c (Figures 1D and S1A). A quantitative single-cell analysis
demonstrated that at least 80% of the Parkin-expressing,
CCCP-treated SVECor 3T3-SA cells were depleted ofmitochon-
dria as evidenced by loss of punctate, mitochondrial Tom20
staining (Figure 1C). A time-course analysis of mitochondrial
depletion revealed initial mitochondrial fragmentation followed
by aggregation and progressive depletion to below the level of
detection (Figure S1B), as in previous studies (Lee et al., 2010;
Narendra et al., 2010). Consistent with a penetrant removal of
mitochondria, short-term treatment with CCCP completely
abolished the clonogenic capacity of Parkin-expressing SVEC
and 3T3-SA cells (Figure S1C). We further observed a dramatic
loss of mitochondrial cytochrome c and Tom20 protein in
SVEC Parkin- or 3T3-SA Parkin-expressing cells following
CCCP treatment (Figures 1D and S1A). Treated cells were
selectively depleted of mtDNA (Figure 1E), lacked oxygen con-
sumption (Figure 1F), and were defective in glutaminolysis (Fig-
ure S1D). Mitochondria-deficient cells were viable and persisted
in culture for up to several days (Figure S1E), as previously
described (Narendra et al., 2008).
TNF-Dependent Necroptosis Does Not Require
Mitochondria
To rigorously determine the extent of mitochondrial depletion,
we carried out transmission electron microscopy (TEM) and
three-dimensional electron microscopy (3D-EM) of Parkin-ex-
pressing 3T3-SA cells. CCCP treatment of these cells effectively
eliminated mitochondria to undetectable levels (Figures 2A–2C;
Movies S2 and S3). It should be noted that although the mito-
chondria were nearly completely depleted, as assessed by 3D-
EM, we nevertheless detected a low level of mtDNA (Figure 1E),
which may represent undegraded DNA in lysosomes. These(E) Mitochondria depletion was triggered in 3T3-SA cells by CCCP treatment for 48
Sytox Green uptake over time in an IncuCyte imager. Error bars represent the S
(F) Mitochondria depletion was triggered in 3T3-SA cells by CCCP treatment fo
assayed using Sytox Green uptake over time in an IncuCyte imager. Error bars r
See also Movies S2 and S3.
Cecells were subjected to treatment to induce necroptosis using
TNF+zVAD, with or without the RIPK1 inhibitor necrostatin-1
(Nec1), for 8 hr. Despite nearly complete depletion of mitochon-
dria, these cells displayed extensive Nec-1-inhibitable cell death
in response to this treatment, as detected by uptake of propi-
dium iodide (PI; 20% versus 21% in control cells without
CCCP treatment; data not shown).
3T3-SA or SVEC cells expressing Parkin were then treated
with CCCP for 2 days, followed by treatment with TNF+zVAD
to induce necroptosis, with or without Nec-1. Alternatively, cells
were treated with TNF plus cycloheximide (CHX), staurosporine
(STS), or actinomycin D (ActD) to trigger apoptosis. Cell death
was measured by PI exclusion. Immunoblotting for cytochrome
c and Tom20 demonstrated effective removal of mitochondria in
Parkin-expressing 3T3-SA or SVEC cells following CCCP treat-
ment (Figures 1D and S1A). Mitochondria-depleted 3T3-SA
and SVEC cells expressing Parkin displayed resistance to
apoptosis (Figure 2D). Importantly, TNF+zVAD-induced necrop-
tosis occurred to the same extent in both 3T3-SA and SVEC
Parkin-expressing cells irrespective of CCCP treatment, and
this was inhibited by Nec-1 (Figure 2D). Cell death induced in
3T3-SA cells by TNF+zVAD (necroptosis) or Act D (apoptosis)
was then examined by live-cell imaging. Although mitochon-
dria-depleted CCCP-treated 3T3-SA cells expressing Parkin
were protected from Act D-induced apoptosis (Figure 2E), the
kinetics and extent of necroptosis were identical in 3T3-SA cells
expressing Parkin irrespective of CCCP treatment (Figure 2F).
Collectively, these data demonstrate that mitochondria are not
required for TNF+zVAD-induced necroptosis.
Direct Induction of Programmed Cell Death
Demonstrates a Role for Mitochondria in Apoptosis
but Not in Programmed Necrosis
To gain a better understanding of the effector mechanisms that
act downstream of RIPK3 in programmed necrosis, we con-
structed a system in which this form of cell death is specifically
induced independently of the pleiotropic effects of TNF. We
employed inducible dimerization, which uses modified regions
of the protein FKBP12 and a rapamycin-derived dimerizer. We
generated an induced-active (ac) form of RIPK3 by fusing tan-
dem dimerization domains to the RIPK3 C terminus (Figure 3A).
Similarly, an acCaspase-8 was utilized to trigger apoptosis, as
described previously (Muzio et al., 1998; Oberst et al., 2010).
To characterize the function of acRIPK3, we stably expressed
either full-length murine RIPK3 or acRIPK3 in NIH 3T3 cells,
which do not express endogenous RIPK3 (He et al., 2009). The
levels of expression of acRIPK3 in these cells and endogenous
RIPK3 in 3T3-SA cells appeared similar (Figure S2A). We found
that when 3T3 NIH cells expressing either RIPK3 or acRIPK3
were treated with TNF+zVAD, they underwent cell death, which
was inhibited by the RIPK1 inhibitor Nec-1 (Figure 3B). However,
when treated with dimerizer, acRIPK3-expressing cellshr and cells were treatedwith ActD as indicated. Cell death was assayed using
D from the mean of three independent experiments.
r 48 hr, and cells were treated with TNF+zVAD as indicated. Cell death was
epresent the SD from the mean of three independent experiments.
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Figure 3. Direct Induction of Programmed Cell Death Demonstrates a Role for Mitochondria in Apoptosis but Not in Programmed Necrosis
(A) Schematic representation of the fusion proteins used to directly induce apoptosis (acCaspase-8) or programmed necrosis (acRIPK3).
(B) NIH 3T3 cells stably transduced with RIPK3 or acRIPK3 were treated as indicated, and cell death was determined by PI positivity and flow cytometry 4 hr later.
Error bars represent the SD from the mean of three replicate experiments.
(C) NIH 3T3 cells expressing acRIPK3 and either LZRS vector or Parkin-LZRS were treated with CCCP as indicated to induce elimination of mitochondria. Cell
death was induced 48 hr later by the treatments indicated. Error bars represent the SD from the mean of three replicate experiments.
(D) NIH 3T3 cells expressing acRIPK3 were treated to deplete mitochondria, and cell death was quantified with an IncuCyte imager. Sytox-positive cell counts
were normalized to total cell numbers using the cell-permeable dye Syto24. Error bars represent the SD from the mean of three independent experiments.
(E) NIH 3T3 cells expressing acCaspase-8 and either LZRS vector or Parkin-LZRS were treated with CCCP as indicated to induce elimination of mitochondria as
described in Figure 1. Cell death was induced 48 hr later by the treatments indicated. Left: representative images. Right: the percentage of cells displaying
Annexin V positivity was analyzed 8 hr after treatment by flow cytometry. Error bars represent the SD from three replicate experiments.
See also Figure S2.
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Figure 4. Elimination of Mitochondria Pre-
vents Necroptosis-Associated ROS Produc-
tion but Does Not Alter RIPK3-Dependent
Cell Death
(A) NIH 3T3 cells expressing acRIPK3 and Parkin
were treated with CCCP to induce mitochondrial
elimination and then treated with TNF+zVAD for
2 hr in the presence of the ROS scavenger BHA or
NAC. ROS production was measured using the
dye DCF. Results shown are the mean ± SD of nR
3 independent experiments. *p < 0.001. Black
dotted line corresponds to the basal level of ROS in
the control at t = 0.MFI, mean fluorescent intensity.
(B) NIH 3T3 cells were treated as in (A) for 4 hr and
then stained with PI. Cell death was determined by
flow cytometry (mean ± SD of nR 3 independent
experiments). *p < 0.05, **p = 0.0518 (t test).
(C) Mitochondria were depleted as in (A), and
RIPK3 dimerization was triggered in the presence
of BHA or NAC. Cell death was quantified 2 hr later
as in (B) (mean ± SD of n R 3 independent
experiments).
(D) Mitochondria depletion was triggered in NIH
3T3 cells as in (A), and cells were then treated with
TNF+zVAD and BHA as indicated. Cell death was
measured by Sytox Green uptake over time in
an IncuCyte imager. Error bars represent the SD
from the mean of triplicate samples. Data are
representative of three independent experiments.
See also Figure S3.underwent rapid cell death, whereas RIPK3-expressing cells
were unaffected. The cell death observed upon dimerizer-
induced activation of acRIPK3 did not require zVAD addition
and was not inhibited by Nec-1, consistent with direct activation
of RIPK3 by dimerization (Figure 3B).
Mixed lineage kinase like (MLKL) is an essential mediator of
RIPK3-dependent necrosis (Sun et al., 2012; Wu et al., 2013;
Zhao et al., 2012). Consistent with this role, knockdown of
MLKL attenuated TNF+zVAD-induced death of RIPK3-express-
ing NIH 3T3 cells, and cell death induced by either TNF+zVAD
or dimerizer treatment in NIH 3T3 cells expressing acRIPK3
(Figure S2B). AcRIPK3 oligomerization required the kinase activ-
ity of RIPK3 to cause necroptosis (Figure S2C), as expected
(He et al., 2009). Therefore, RIPK3 oligomerization most likely
induces cell death by the same effector mechanism induced by
TNF+zVAD.
We next evaluated the effects of depleting mitochondria in
cells expressing acCaspase-8 or acRIPK3. Parkin effectively
depleted mitochondria in acCaspase-8- or acRIPK3-expres-
sing NIH 3T3 cells (Figures S2D and S2E). We found that
upon removal of mitochondria, cell death triggered by either
TNF+zVAD or dimerizer was unchanged with respect to extent
(Figure 3C) or kinetics (Figure 3D). In contrast, in NIH 3T3 cells
stably expressing acCaspase-8, we found that depletion ofmito-
chondria substantially blocked apoptosis-induced dimerizer or
ActD treatment (Figure 3E). The requirement for mitochondria
in the Caspase-8-induced apoptotic response is consistent
with the ‘‘type II’’ response to DR ligation, in which mitochondrial
outer membrane permeabilization is required for antagonism of
XIAP (Jost et al., 2009).CeRoles for themitochondrial phosphatase PGAM5and the regu-
lator ofmitochondrial fissionDRP1 in the execution of necroptosis
were recently proposed (Wang et al., 2012). In line with its mito-
chondrial localization, PGAM5was effectively depleted fromPar-
kin-expressing cells following CCCP treatment, whereas Drp-1
was unaffected (Figure S2F). However, we failed to observe a
role for either protein in our systems (Figure S2). Although knock-
down of PGAM5 depleted protein levels (Figure S2G), it did not
affect necroptosis inducedby TNFor direct activation of acRIPK3
in NIH 3T3 cells (Figure S2H), or in response to TNF+zVAD
treatment of 3T3-SA or SVEC cells expressing endogenous
RIPK3 (Figure S2J). Furthermore, whereas knockdown of DRP1
(Figure S2G) caused extensivemitochondrial fusion, as expected
(Figure S2I), we observed no effect on necroptosis (Figures S2H
and S2J). While silencing of these proteins cannot be taken as a
formal demonstration that they are not involved in necroptosis,
our findings prohibited us from further exploring any possible
extramitochondrial roles for PGAM5 or DRP1 in the process.
Elimination of Mitochondria Prevents
Necroptosis-Associated ROS Production but
Does Not Alter RIPK3-Dependent Cell Death
Investigators have proposed a role for mitochondria in necropto-
sis largely on the basis of its associationwith a ROSburst and the
finding that the ROS scavenger butylated hydroxyanisole (BHA)
effectively delays cell death induced by TNF+zVAD (He et al.,
2011; Vanden Berghe et al., 2010). We found that TNF+zVAD
induced RIPK3-dependent ROS that was efficiently inhibited
by BHA or by another scavenger, N-acetylcysteine (NAC) (Fig-
ure 4A). Strikingly, depletion of mitochondria prevented thisll Reports 5, 878–885, November 27, 2013 ª2013 The Authors 883
ROS burst (Figure 4A). Similar results were found in 3T3-SA cells
expressing Parkin (Figure S3B). However, although BHA
effectively inhibited necroptosis induced by TNF+zVAD, neither
NAC nor mitochondrial depletion influenced cell death (Figures
4B and S3A). This effect of BHAwas not observedwhen necrosis
was induced by direct activation of acRIPK3 (Figure 4C).
Remarkably, the ability of BHA to partially inhibit necroptosis
induced by TNF+zVAD was also observed in cells that were
depleted of mitochondria (Figure 4D).
The effect of BHA on necroptosis is therefore independent of
mitochondrial ROS, and thus is an ‘‘off-target’’ effect. BHA has
been shown to compromise a number of mitochondrial functions
in addition to ROS production, including inhibition of Phospholi-
pase-A2 (Festjens et al., 2006), which has also been implicated in
necroptosis (Cauwels et al., 2003). However, the failure of BHA to
influence necroptosis induced by oligomerization of acRIPK3,
and our failure to identify a role for mitochondria in cell death
induced by TNF+zVAD or direct activation of RIPK3 suggest
that any effects of BHA or other manipulations of mitochondrial
functions (Wang et al., 2012) on necroptosis may act upstream
of the engagement of RIPK3 activation.DISCUSSION
Our results strongly argue against a major role for mitochondria
as effectors of necroptosis. These findings, as well as the striking
rapidity with which RIPK3 activation leads to necrotic death (e.g.,
Figure S2C), suggest that necroptosis is unlikely to occur via
subtle metabolic processes (Zhang et al., 2009) or ROS (Cho
et al., 2009). Nevertheless, as roles for necroptosis have been
identified in developmental defects (Dillon et al., 2012; Oberst
et al., 2011), ischemic injury (Linkermann et al., 2012; Rose-
nbaum et al., 2010), and other pathologies (He et al., 2009), un-
derstanding the way in which RIPK3 mediates its lethal activity
remains of great interest.
During early explorations of the mechanisms of apoptosis, it
was widely held that the process relied on nuclear events and/
or mitochondrial ROS. Important progress was made when it
was demonstrated that apoptotic cell death proceeds in cells
from which the nuclei have been removed (Jacobson et al.,
1994; Schulze-Osthoff et al., 1994) and in cells from which mito-
chondrial DNA had been depleted (Jacobson et al., 1993). In our
studies, we followed a similar logic: if necroptosis is affected by
mitochondria, then artificial depletion of mitochondria from a cell
should impact the process of necroptosis. Although our studies
do not provide a final effector mechanism for this form of cell
death, we conclude that efforts to link RIPK3 activation and
MLKL to the mitochondria will not be informative for elucidating
how cells die by this important process.EXPERIMENTAL PROCEDURES
Plasmids and Retroviral Transduction
mCherry-Parkin-internal ribosome entry site (IRES)-zeocin and yellow fluores-
cent protein (YFP)-Parkin-IRES-zeocin were generated by ligating mCherry C1
Parkin and enhanced YFP C1 Parkin (both provided by Dr. Richard Youle) into
the LZRS vector (Tait et al., 2010) using standard cloning techniques (see also
Supplemental Experimental Procedures).884 Cell Reports 5, 878–885, November 27, 2013 ª2013 The AuthorsMicroscopy
Live-cell imaging was carried out by spinning-disk confocal microscopy using
a Marianas SDC imaging system (for Annexin V/PI/TMRE) or by laser scanning
microscopy using a Nikon A1R system for Mitotracker Green (see also Supple-
mental Experimental Procedures).
RNAi and Western Blot
Cells (5 3 104) were transfected with control or Smartpool RNAi duplexes
(Dharmacon) targeting murine MLKL, PGAM5, or Drp-1. Duplexes were trans-
fected twice on consecutive days with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Cells were analyzed 3 days after
the initial transfection (see also Supplemental Experimental Procedures).
Clonogenicity Assay, Treatments, and Cell Death Assays
Cells were seeded in 12-well plates (53 103 cells per well) and left untreated or
treated with CCCP (12.5 mM) two times over a 24 hr period, after which time it
was washed out and replaced with complete media. Colonies were stained
with methylene blue solution (1% w/v methylene blue in a 50:50 methanol/
water solution; see also Supplemental Experimental Procedures).
Seahorse Oxygen Consumption Assay, mtDNA, and ROS
Quantification
Respiration was measured with a Seahorse XF24 analyzer. Cells were seeded
in plates coated with poly-L-lysine. After 5 hr, the cells were loaded into the
machine to determine the oxygen consumption rate (see also Supplemental
Experimental Procedures).
Generation of cyclophilinD-ko/caspase-8 het Mice and Statistical
Analysis
To generate cyclophilinD-KO/caspase-8 HET mice, we crossed cyclophilin
D-KO mice (B6;129-Ppif tm1Jmol/J, order no. 009071; The Jackson Labora-
tory; described in Nakayama et al., 2007) with caspase-8/RIPK3-DKO mice
(Oberst et al., 2011; see also Supplemental Experimental Procedures).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.10.034.
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